Clonality and loss of heterozygosity are associated with prognosis and subtypes in high grade serous ovarian cancer

被引：0
|
作者：
Takaya, Hisamitsu
Nakai, Hidekatsu
Sakai, Kazuko
Nishio, Kazuto
Matsumura, Noriomi
机构：
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-2006
引用
收藏
页码：640 / 640
页数：1
相关论文
共 50 条
  • [1] Association of high-grade serous ovarian cancer sample clonality with clinical outcomes
    Ulmer, Keely
    Stephens, Harvey
    Gabrilovich, Sofia
    Polio, Andrew
    Bender, David
    Goodheart, Michael
    Bosquet, Jesus Gonzalez
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S142 - S142
  • [2] CHEMOTHERAPY INDUCE OLIGOCLONALITY AND HIGH CLONALITY RELATED WITH RECURRENCE IN HIGH GRADE SEROUS OVARIAN CANCER
    Takaya, H.
    Nakai, H.
    Murakami, K.
    Kotani, Y.
    Suzuki, A.
    Mandai, M.
    Matsumura, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 484 - 484
  • [3] Expression of inflammatory biomarkers is associated with prognosis in patients with high-grade serous ovarian cancer
    Brzezinska, Bogna
    Mysona, David
    Richardson, Katherine
    Purohit, Sharad
    Suhner, Jessa
    Vaz, Jennifer
    Johnson, Marian
    Higgins, Robert
    Rungruang, Bunja
    Ghamande, Sharad
    McIndoe, Richard
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S303 - S304
  • [4] CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer
    Turcotte, Martin
    Spring, Kathleen
    Pommey, Sandra
    Chouinard, Guillaume
    Cousineau, Isabelle
    George, Joshy
    Chen, Gregory M.
    Gendoo, Deena M. A.
    Haibe-Kains, Benjamin
    Karn, Thomas
    Rahimi, Kurosh
    Le Page, Cecile
    Provencher, Diane
    Mes-Masson, Anne-Marie
    Stagg, John
    CANCER RESEARCH, 2015, 75 (21) : 4494 - 4503
  • [5] VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer
    Liju Zong
    Yuncan Zhou
    Ming Zhang
    Jie Chen
    Yang Xiang
    Cancer Immunology, Immunotherapy, 2020, 69 : 33 - 42
  • [6] VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer
    Zong, Liju
    Zhou, Yuncan
    Zhang, Ming
    Chen, Jie
    Xiang, Yang
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (01) : 33 - 42
  • [7] Loss of heterozygosity (LOH), malignancy grade and clonality in microdissected prostate cancer
    A Hügel
    N Wernert
    British Journal of Cancer, 1999, 79 : 551 - 557
  • [8] Loss of heterozygosity (LOH), malignancy grade and clonality in microdissected prostate cancer
    Wernert, N
    Hügel, A
    JOURNAL OF MOLECULAR MEDICINE-JMM, 1999, 77 (04): : B10 - B10
  • [9] Loss of heterozygosity (LOH), malignancy grade and clonality in microdissected prostate cancer
    Hügel, A
    Wernert, N
    BRITISH JOURNAL OF CANCER, 1999, 79 (3-4) : 551 - 557
  • [10] Molecular Subtypes of High-Grade Serous Ovarian Cancer: The Holy Grail?
    Waldron, Levi
    Riester, Markus
    Birrer, Michael
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (10):
12345